The seasonal importance of serum 25-hydroxyvitamin D for bone mineral density in older women

Journal of Internal Medicine

Volumn 281, Issue 2, 2017, Pages 167-178

  Michaelsson K ^a   Wolk, A ^b   Byberg, L ^a   Mitchell, A ^a   Mallmin, H ^a   Melhus, H ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

25 hydroxyvitamin D; bone mineral density; season; vitamin D; vitamin D intake

Indexed keywords

25 HYDROXYVITAMIN D; CALCIFEDIOL; CALCIUM; CREATININE; CYSTATIN C; OSTEOCALCIN; PARATHYROID HORMONE; SERUM ALBUMIN; 25-HYDROXYVITAMIN D; CALCIUM INTAKE; VITAMIN D;

AGED; AGING; ARTICLE; AUTUMN; BLOOD SAMPLING; BONE DENSITY; CALCIUM BLOOD LEVEL; CLINICAL EXAMINATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIP; HUMAN; LEISURE; LIFESTYLE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LONGITUDINAL STUDY; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SEASONAL VARIATION; SPRING; SUMMER; SWEDISH CITIZEN; VITAMIN BLOOD LEVEL; ADMINISTRATION AND DOSAGE; ANALOGS AND DERIVATIVES; BLOOD; CALCIUM INTAKE; DIETARY SUPPLEMENT; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHYSIOLOGY; RISK FACTOR; SEASON; SWEDEN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; SEASONS; SWEDEN; VITAMIN D;

EID: 85010471763     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12563     Document Type: Article

References (44)

1. Ross AC, Manson JE, Abrams SA et al. The report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53–8.
2. Webb AR, Engelsen O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 2006; 82: 1697–703.
3. van der Mei IAF, Ponsonby A-L, Engelsen O et al. The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect 2007; 115: 1132–9.
4. Kull M, Kallikorm R, Tamm A, Lember M. Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country. BMC Public Health 2009; 9: 22.
5. Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V. Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women. J Clin Endocrinol Metab 2002; 87: 2024–32.
6. Gozdzik A, Barta JL, Weir A et al. Serum 25-hydroxyvitamin D concentrations fluctuate seasonally in young adults of diverse ancestry living in Toronto. J Nutr 2010; 140: 2213–20.
7. Lucas J, Bolland M, Grey A et al. Determinants of vitamin D status in older women living in a subtropical climate. Osteoporos Int 2005; 16: 1641–8.
8. Klenk J, Rapp K, Denkinger MD et al. Seasonality of vitamin D status in older people in Southern Germany: implications for assessment. Age Ageing 2013; 42: 404–8.
9. Grimnes G, Almaas B, Eggen AE et al. Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 2010; 163: 339–48.
10. Pasco JA, Henry MJ, Kotowicz MA et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong osteoporosis study. J Bone Miner Res 2004; 19: 752–8.
11. Burgaz A, Åkesson A, Michaëlsson K, Wolk A. 25-hydroxyvitamin D accumulation during summer in elderly women at latitude 60°N. J Intern Med 2009; 266: 476–83.
12. van Schoor NM, Knol DL, Deeg DJH, Peters FPAMN, Heijboer AC, Lips P. Longitudinal changes and seasonal variations in serum 25-hydroxyvitamin D levels in different age groups: results of the Longitudinal Aging Study Amsterdam. Osteoporos Int 2014; 25: 1483–91.
13. Vanderschueren D, Gevers G, Dequeker J et al. Seasonal variation in bone metabolism in young healthy subjects. Calcif Tissue Int 1991; 49: 84–9.
14. Warensjo E, Byberg L, Melhus H et al. Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ 2011; 342: d1473.
15. Snellman G, Byberg L, Lemming EW et al. Long-term dietary vitamin D intake and risk of fracture and osteoporosis: a longitudinal cohort study of Swedish middle-aged and elderly women. J Clin Endocrinol Metab 2014; 99: 781–90.
16. Melhus H, Snellman G, Gedeborg R et al. Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab 2010; 95: 2637–45.
17. Bedner M, Lippa KA, Tai SS. An assessment of 25-hydroxyvitamin D measurements in comparability studies conducted by the Vitamin D Metabolites Quality Assurance Program. Clin Chim Acta 2013; 426: 6–11.
18. McKinlay AFD, Diffey BL. A reference action spectrum for ultraviolet induced erythema in human skin. CIE Research Note. CIE J 1987; 6: 17–22.
19. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702–6.
20. Rautiainen S, Akesson A, Levitan EB, Morgenstern R, Mittleman MA, Wolk A. Multivitamin use and the risk of myocardial infarction: a population-based cohort of Swedish women. Am J Clin Nutr 2010; 92: 1251–6.
21. Imbens GW. The role of the propensity score in estimating dose-response functions. Biometrika 2000; 87: 706–10.
22. Grubb A, Nyman U, Bjork J. Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine. Scand J Clin Lab Invest 2012; 72: 73–7.
23. Gahche J, Bailey R, Burt V et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994). NCHS Data Brief 2011; 61: 1–8.
24. McCormack D, Mai X, Chen Y. Determinants of vitamin D supplement use in Canadians. Public Health Nutr 2015; 19: 1–7.
25. Morioka TY, Bolin JT, Attipoe S, Jones DR, Stephens MB, Deuster PA. Trends in vitamin A, C, D, E, K supplement prescriptions from military treatment facilities: 2007 to 2011. Mil Med 2015; 180: 748–53.
26. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2014; 383: 146–55.
27. Snellman G, Melhus H, Gedeborg R et al. Determining vitamin D status: a comparison between commercially available assays. PLoS One 2010; 5: e11555.
28. Wyness SP, Straseski JA. Performance characteristics of six automated 25-hydroxyvitamin D assays: Mind your 3s and 2s. Clin Biochem 2015; 48: 1089–96.
29. Gallagher JC, Jindal PS, Smith LM. Vitamin D does not increase calcium absorption in young women: a randomized clinical trial. J Bone Miner Res 2014; 29: 1081–7.
30. Gallagher JC, Yalamanchili V, Smith LM. The effect of vitamin D on calcium absorption in older women. J Clin Endocrinol Metab 2012; 97: 3550–6.
31. Reid IR. Effects of vitamin D supplements on bone density. J Endocrinol Invest 2015; 38: 91–4.
32. Jones KS, Schoenmakers I, Bluck LJ, Ding S, Prentice A. Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults. Br J Nutr 2012; 107: 1128–37.
33. Rice SA, Carpenter M, Fityan A et al. Limited exposure to ambient ultraviolet radiation and 25-hydroxyvitamin D levels: a systematic review. Br J Dermatol 2015; 172: 652–61.
34. Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 1972; 43: 413–31.
35. Didriksen A, Burild A, Jakobsen J, Fuskevag OM, Jorde R. Vitamin D3 increases in abdominal subcutaneous fat tissue after supplementation with vitamin D3. Eur J Endocrinol 2015; 172: 235–41.
36. Blum M, Dolnikowski G, Seyoum E et al. Vitamin D(3) in fat tissue. Endocrine 2008; 33: 90–4.
37. Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012; 20: 1444–8.
38. Gangloff A, Bergeron J, Pelletier-Beaumont E et al. Effect of adipose tissue volume loss on circulating 25-hydroxyvitamin D levels: results from a 1-year lifestyle intervention in viscerally obese men. Int J Obes 2015; 39: 1638–43.
39. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998; 351: 805–6.
40. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005; 294: 2336–41.
41. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 2004; 15: 255–65.
42. Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2010; 19: 927–31.
43. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010; 171: 903–8.
44. Mayhew PM, Thomas CD, Clement JG et al. Relation between age, femoral neck cortical stability, and hip fracture risk. Lancet 2005; 366: 129–35.